Performance Health plans to launch Biofreeze topical pain reliever over the counter at retail stores beginning this fall. The company said Saturday that Biofreeze cold therapy gel will be sold at drug store, supermarket and mass merchant retailers.
Bell Pharmaceuticals is working to grow retail distribution of the latest additions to its Jet-Alert product family, Jet-Asleep and Jet-Avert. Jet-Asleep has gained placement at major retailers such as Dollar General and regional drug chains Kinney Drugs and Discount Drug Mart.
H.D. Smith has recognized pharmaceutical and health product manufacturers with its annual Trading Partners of the Year awards.
Health care giant Johnson & Johnson is sharpening its aim at the growing diabetes epidemic.
Apothecary Products LLC has purchased Health Enterprises Inc., a manufacturer and distributor of consumer health care products and pharmacy supplies. Financial terms of the deal weren’t disclosed. Apothecary Products said Health Enterprises, which is based in North Attleboro, Mass.
Compass Health Brands has acquired home health care manufacturer and supplier Meridian Medical LLC. Financial terms of the agreement weren’t disclosed. Knoxville, Tenn.
Another large deal has been struck between Allergan plc and Teva Pharmaceutical Industries Ltd. The companies on Wednesday announced the sale of Allergan’s Anda Inc. distribution business to Teva for $500 million.
Mayne Pharma has completed its purchase of a package of generic drug products from Teva Pharmaceutical Industries Ltd. and Allergan plc. Mayne said Wednesday that under the $652 million deal, announced in late June, it takes ownership of 37 approved and five filed generic pharmaceutical products.
Kleenex has begun rolling out its Kleenex Facial Cleansing product collection to major online retailers.
Teva Pharmaceutical Industries Ltd. has closed its acquisition of the Allergan plc generics business. The companies said Tuesday that under the deal, announced last July, Allergan receives $33.4 billion in cash and 100.3 million shares of Teva stock, valued at $5.
Ateb Inc. plans to integrate pharmacy performance and measurement data from the Pharmacy Quality Solutions (PQS) EQuIPP system into its Patient Management Access Portal (PMAP).
Pharmacy automation provider Innovation has entered into a technology integration agreement with IMA North America.
Mylan N.V. this week introduced two new generic drugs in the U.S. market. On Monday, the company announced final Food and Drug Administration approval for dextroamphetamine sulfate extended-release capsules — in dosages of 5 mg, 10 mg and 15 mg — and finasteride tablets 1 mg.
Forrest E. Mars Jr., heir to candy giant Mars Inc. and its former co-president, has died at age 84. Mars Jr., who passed away on July 26, was the eldest son of Audrey and Forrest E. Mars Sr. and the grandson of Frank C. Mars, the founder of Mars Inc. With his brother
Steven Dinh has joined CutisPharma as executive vice president and chief scientific officer. CutisPharma said Monday that Dinh will play a key role at the company, overseeing its efforts to develop its pipeline of drugs for New Drug Application (NDA) submission to the Food and Drug Administration.
Merix Pharmaceutical Corp. has entered into a strategic business alliance with Athens, Greece-based consumer product company Sarantis Group. Terms of the agreement weren’t disclosed.
